ACH (ACH) Stock Analysis
Verdict: AVOID
Severe balance sheet distress with -$461M equity and $2.23B debt makes ACH a high-dilution or restructuring risk despite home health assets.
Investment score: 13/100
The model sees Accendra Health as a distressed medical distributor in critical balance sheet territory. With negative net equity and $2.23B in debt, the risk of capital restructuring dominates the outlook.